Advanced T1D patients showed significant improvement in fasting blood glucose (P = .021) and insulin dose-adjusted HbA1c (P = .031), but not in C-peptide and HbA1c levels (Rabinovitch et al, 2023). This evidence concerns the gene INS and type 1 diabetes mellitus.